When patients start getting treated for conditions like psoriatic arthritis, or connective tissue diseases like lupus and systemic sclerosis, their heightened risk of cancer gradually decreases, according to a new five-year study tracking people with immune-mediated inflammatory diseases (IMID). Scientists theorize that the anti-inflammatory treatment for these diseases provides potential protective effects, reversing the increased cancer risk caused by high inflammation.
This article was originally published on MedicalXpress.com
